Shop by goal

Popular compounds

GHK-Cu

Retatrutide

Research resources

Certificates of Analysis

IGF-DES: Muscle / Performance research guide

In short: IGF-DES is IGF-1 with its first three N-terminal residues removed - a truncated analogue whose sharply reduced IGFBP affinity makes it far more potent locally but very short-lived in circulation. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

Not medical advice. IGF-DES is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

IGF-DES at a glance

Compound type

Research peptide

Research category

Muscle / Performance

Also known as

IGF-DES, IGF-1 DES(1-3), DES(1-3)IGF-1, des-tripeptide IGF-1, truncated IGF-1

Molecular weight

≈7,371 Da (67 residues)

Research-grade purity

>98% HPLC

Evidence context

Preclinical / research use only

Regulatory status

Not an approved medicine. Supplied as a research compound

Last reviewed

6 August 2026

What to know first

Truncated IGF-1 analogue missing the N-terminal Gly-Pro-Glu tripeptide (67 residues)

Roughly 100-fold lower affinity for the IGF binding proteins than intact IGF-1

Reported several-fold greater potency than IGF-1 in cell and tissue models

Short circulating persistence - the binding proteins that prolong IGF-1 no longer retain it

Details and limits sit in the sections below. Research use only.

What IGF-DES is

IGF-DES is DES(1-3)IGF-1: insulin-like growth factor 1 missing its first three residues, which strips away most binding-protein control and converts a long-acting systemic hormone into a short, locally potent signal.

One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

IGF-DES is IGF-1 with its first three N-terminal residues removed - a truncated analogue whose sharply reduced IGFBP affinity makes it far more potent locally but very short-lived in circulation.

Research contexts

Peer-reviewed papers discuss IGF-DES in specific lab settings. The points below reflect research questions, not health claims.

Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

Typical study contexts

Muscle injury, overload or culture models of growth-factor cascades.

IGF/IGFBP biology in cell lines and animals. Signalling questions, not “gains”.

Truncated IGF-1 analogue missing the N-terminal Gly-Pro-Glu tripeptide (67 residues).

Roughly 100-fold lower affinity for the IGF binding proteins than intact IGF-1.

Reported several-fold greater potency than IGF-1 in cell and tissue models.

Short circulating persistence - the binding proteins that prolong IGF-1 no longer retain it.

Why Muscle / Performance research matters

Here the literature centres on muscle repair and growth-factor signalling after overload or injury in preclinical work.

Mechanisms (technical review)

Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

Truncated IGF-1 analogue missing the N-terminal Gly-Pro-Glu tripeptide (67 residues)

Roughly 100-fold lower affinity for the IGF binding proteins than intact IGF-1

Reported several-fold greater potency than IGF-1 in cell and tissue models

Short circulating persistence - the binding proteins that prolong IGF-1 no longer retain it

Signals through the same IGF-1 receptor and downstream PI3K/Akt and MAPK pathways

A standard research tool for isolating receptor effects from binding-protein effects

Lab handling & preparation

Storage: Lyophilised powder: store in freezer (−20 °C), protected from light and moisture. Reconstituted: refrigerate 1–6 °C and use promptly - as a small protein it is susceptible to surface adsorption and to loss of activity on repeated freeze-thaw, so aliquot after reconstitution. Use within the validated stability window for the specific batch.. See the storage guide.

Research dosing context: Literature typically discusses Reported in the research literature as nanomolar concentrations in culture, or as microgram-scale amounts in animal studies. Study-dependent; the short half-life means published protocols favour frequent or local administration over systemic dosing Because IGF-DES escapes binding-protein capture, the concentrations used in published cell work are typically well below those needed for intact IGF-1 to produce a comparable response - direct substitution at equal mass is not how the literature treats it. Its persistence is correspondingly short, on the order of tens of minutes rather than hours. These figures describe the research context and are not a dosing recommendation. Material is for laboratory research only.

Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.

Purity check: Use the COA reading guide and the published IGF-DES Certificate of Analysis.

Common Questions People Are Asking

What is IGF-DES used for in research?

It is used as a tool for studying IGF-1 receptor signalling without the confounding influence of the binding-protein system - commonly in muscle and satellite-cell work, and in potency-benchmarking experiments run alongside intact IGF-1.

How does IGF-DES differ from IGF-1 LR3?

Both are IGF-1 analogues engineered to evade the binding proteins, but by opposite means. IGF-DES removes the N-terminal tripeptide, giving very low IGFBP affinity and a very short half-life. IGF-1 LR3 substitutes Arg at position 3 and adds a 13-residue N-terminal extension, which also reduces IGFBP binding but produces a much longer-lived molecule. Short and local versus long and systemic.

Why is IGF-DES described as more potent than IGF-1?

Mostly because more of it is free. Intact IGF-1 is over 95% bound in circulation, so only a small fraction reaches the receptor at any moment; IGF-DES largely escapes that capture. The reported several-fold potency advantage is therefore better read as an availability effect than as evidence the truncated protein is intrinsically a stronger agonist at the receptor.

Is IGF-DES a synthetic molecule?

Not exclusively. DES(1-3)IGF-1 occurs naturally - it has been identified in bovine colostrum and in human brain tissue. The research-grade material supplied here is produced synthetically, but the molecule itself is a natural truncation product of IGF-1.

How should IGF-DES be reconstituted and stored?

Keep the lyophilised powder frozen at −20 °C, protected from light and moisture. Protocols commonly use dilute acetic acid water for the initial dissolution because the protein is poorly soluble at neutral pH, then dilute with bacteriostatic water. Refrigerate the solution at 1–6 °C, aliquot it, and avoid repeated freeze-thaw cycles - as a small protein it also adsorbs to container surfaces, so low-binding tubes are common in the literature.

Is this page medical advice? Can I use IGF-DES for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find IGF-DES specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside IGF-DES.

IGF-1 LR3 - companion guide

PEG-MGF - companion guide

MGF - companion guide

TB-500 - companion guide

Scientific sources & further reading

Primary literature and registries for IGF-DES, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on IGF-DES

ClinicalTrials.gov: registered studies on IGF-DES

IGF-DES: Wikipedia

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: IGF-DES, IGF-1 DES(1-3), DES(1-3)IGF-1, des-tripeptide IGF-1, truncated IGF-1

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research